Skip to main content
Top
Published in: Abdominal Radiology 1/2017

Open Access 01-01-2017

Diffusion-weighted imaging for evaluating inflammatory activity in Crohn’s disease: comparison with histopathology, conventional MRI activity scores, and faecal calprotectin

Authors: D. A. Pendsé, J. C. Makanyanga, A. A. Plumb, G. Bhatnagar, D. Atkinson, Manuel Rodriguez-Justo, S. Halligan, S. A. Taylor

Published in: Abdominal Radiology | Issue 1/2017

Login to get access

ABSTRACT

Purpose

To evaluate whether the extent of enteric diffusion-weighted imaging (DWI) signal abnormality reflects inflammatory burden in Crohn’s disease (CD), and to compare qualitative and quantitative grading.

Methods

69 CD patients (35 male, age 16–78) undergoing MR enterography with DWI (MRE-D) and the same-day faecal calprotectin (cohort 1) were supplemented by 29 patients (19 male, age 16–70) undergoing MRE-D and terminal ileal biopsy (cohort 2). Global (cohort 1) and terminal ileal (cohort 2) DWI signal was graded (0 to 3) by 2 radiologists and segmental apparent diffusion coefficient (ADC) calculated. Data were compared to calprotectin and a validated MRI activity score [MEGS] (cohort 1), and a histopathological activity score (eAIS) (cohort 2) using nonparametric testing and rank correlation.

Results

Patients with normal (grades 0 and 1) DWI signal had lower calprotectin and MEGS than those with abnormal signal (grades 2 and 3) (160 vs. 492 μg/l, p = 0.0004, and 3.3 vs. 21, p < 0.0001), respectively. Calprotectin was lower if abnormal DWI affected <10 cm of small bowel compared to diffuse small and large bowel abnormality (236 vs. 571 μg, p = 0.009). The sensitivity and specificity for active disease (calprotectin > 120 μg/l) were 83% and 52%, respectively. There was a negative correlation between ileal MEGS and ADC (r = −0.41, p = 0.017). There was no significant difference in eAIS between qualitative DWI scores (p = 0.42). Mean ADC was not different in those with and without histological inflammation (2077 vs. 1622 × 10−6mm2/s, p = 0.10)

Conclusions

Qualitative grading of DWI signal has utility in defining the burden of CD activity. Quantitative ADC measurements have poor discriminatory ability for segmental disease activity.
Literature
1.
go back to reference Steward MJ, Punwani S, Proctor I, et al. (2011) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81(9):2080–2088CrossRefPubMed Steward MJ, Punwani S, Proctor I, et al. (2011) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81(9):2080–2088CrossRefPubMed
2.
go back to reference Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. (2011) Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis 17(5):1073–1080CrossRefPubMed Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. (2011) Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis 17(5):1073–1080CrossRefPubMed
3.
go back to reference Absah I, Bruining DH, Matsumoto JM, et al. (2012) MR enterography in pediatric inflammatory bowel disease: retrospective assessment of patient tolerance, image quality, and initial performance estimates. AJR Am J Roentgenol 199(3):W367–W375CrossRefPubMed Absah I, Bruining DH, Matsumoto JM, et al. (2012) MR enterography in pediatric inflammatory bowel disease: retrospective assessment of patient tolerance, image quality, and initial performance estimates. AJR Am J Roentgenol 199(3):W367–W375CrossRefPubMed
4.
go back to reference Adamek HE, Schantzen W, Rinas U, et al. (2012) Ultra-high-field magnetic resonance enterography in the diagnosis of ileitis (Neo-)terminalis: a prospective study. J Clin Gastroenterol 46(4):311–316CrossRefPubMed Adamek HE, Schantzen W, Rinas U, et al. (2012) Ultra-high-field magnetic resonance enterography in the diagnosis of ileitis (Neo-)terminalis: a prospective study. J Clin Gastroenterol 46(4):311–316CrossRefPubMed
5.
go back to reference Seo N, Park SH, Kim K-J, et al. (2015) MR enterography for the evaluation of small-bowel inflammation in Crohn disease by using diffusion-weighted imaging without intravenous contrast material: a prospective noninferiority study. Radiology. 000:150809 Seo N, Park SH, Kim K-J, et al. (2015) MR enterography for the evaluation of small-bowel inflammation in Crohn disease by using diffusion-weighted imaging without intravenous contrast material: a prospective noninferiority study. Radiology. 000:150809
6.
go back to reference Kayhan A, Oommen J, Dahi F, Oto A (2010) Magnetic resonance enterography in Crohn’s disease: Standard and advanced techniques. World J Radiol 2(4):113–121CrossRefPubMedPubMedCentral Kayhan A, Oommen J, Dahi F, Oto A (2010) Magnetic resonance enterography in Crohn’s disease: Standard and advanced techniques. World J Radiol 2(4):113–121CrossRefPubMedPubMedCentral
7.
go back to reference Fiorino G, Bonifacio C, Padrenostro M, et al. (2013) Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn’s disease. Dig Dis Sci 58(11):3246–3255CrossRefPubMed Fiorino G, Bonifacio C, Padrenostro M, et al. (2013) Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn’s disease. Dig Dis Sci 58(11):3246–3255CrossRefPubMed
8.
go back to reference Makanyanga JC, Pendsé D, Dikaios N, et al. (2013) Evaluation of Crohn’s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol 24(2):277–287CrossRefPubMed Makanyanga JC, Pendsé D, Dikaios N, et al. (2013) Evaluation of Crohn’s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol 24(2):277–287CrossRefPubMed
9.
go back to reference Rimola J, Rodriguez S, Garcı O, et al. (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58(8):1113–1120CrossRefPubMed Rimola J, Rodriguez S, Garcı O, et al. (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58(8):1113–1120CrossRefPubMed
10.
go back to reference Rimola J, Ordás I, Rodriguez S, et al. (2011) Magnetic resonance imaging for evaluation of Crohn's disease. Inflamm Bowel Dis 17(8):1759–1768CrossRefPubMed Rimola J, Ordás I, Rodriguez S, et al. (2011) Magnetic resonance imaging for evaluation of Crohn's disease. Inflamm Bowel Dis 17(8):1759–1768CrossRefPubMed
11.
go back to reference Buisson A, Joubert A, Montoriol P-F, et al. (2013) Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease. Aliment Pharmacol Ther 37(5):537–545CrossRefPubMed Buisson A, Joubert A, Montoriol P-F, et al. (2013) Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease. Aliment Pharmacol Ther 37(5):537–545CrossRefPubMed
12.
go back to reference Freiman M, Perez-Rossello JM, Callahan MJ, et al. (2013) Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn’s disease. J Magn Reson Imaging 37(1):156–163CrossRefPubMed Freiman M, Perez-Rossello JM, Callahan MJ, et al. (2013) Characterization of fast and slow diffusion from diffusion-weighted MRI of pediatric Crohn’s disease. J Magn Reson Imaging 37(1):156–163CrossRefPubMed
13.
go back to reference Hordonneau C, Buisson A, Scanzi J, et al. (2014) Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol 109(1):89–98CrossRefPubMed Hordonneau C, Buisson A, Scanzi J, et al. (2014) Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol 109(1):89–98CrossRefPubMed
14.
go back to reference Kiryu S, Dodanuki K, Takao H, et al. (2009) Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn’s disease. J Magn Reson Imaging 29(4):880–886CrossRefPubMed Kiryu S, Dodanuki K, Takao H, et al. (2009) Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn’s disease. J Magn Reson Imaging 29(4):880–886CrossRefPubMed
15.
go back to reference Oto A, Kayhan A, Williams JTB, et al. (2011) Active Crohn’s disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging 33(3):615–624CrossRefPubMed Oto A, Kayhan A, Williams JTB, et al. (2011) Active Crohn’s disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging 33(3):615–624CrossRefPubMed
16.
go back to reference Oussalah A, Laurent V, Bruot O, et al. (2010) Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59(8):1056–1065CrossRefPubMed Oussalah A, Laurent V, Bruot O, et al. (2010) Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59(8):1056–1065CrossRefPubMed
17.
go back to reference Lauenstein TC, Schneemann H, Vogt FM, et al. (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228(1):279–283CrossRefPubMed Lauenstein TC, Schneemann H, Vogt FM, et al. (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228(1):279–283CrossRefPubMed
18.
go back to reference Oto A, Zhu F, Kulkarni K, et al. (2009) Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn’s disease. Acad Radiol 16(5):597–603CrossRefPubMedPubMedCentral Oto A, Zhu F, Kulkarni K, et al. (2009) Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn’s disease. Acad Radiol 16(5):597–603CrossRefPubMedPubMedCentral
19.
go back to reference Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30(2):367–384CrossRefPubMed Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30(2):367–384CrossRefPubMed
20.
go back to reference Stange EF, Travis SPL, Vermeire S, et al. (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(Suppl 1):i1–i15CrossRefPubMedPubMedCentral Stange EF, Travis SPL, Vermeire S, et al. (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(Suppl 1):i1–i15CrossRefPubMedPubMedCentral
21.
go back to reference (FDA) USF and DA. PhiCal 510(k) Substantial Equivalence Determination Decision Summary. (FDA) USF and DA. PhiCal 510(k) Substantial Equivalence Determination Decision Summary.
22.
go back to reference Kim K-J, Lee Y, Park SH, et al. (2015) Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis 21(1):101–109CrossRefPubMed Kim K-J, Lee Y, Park SH, et al. (2015) Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis 21(1):101–109CrossRefPubMed
23.
go back to reference Sipponen T, Kärkkäinen P, Savilahti E, et al. (2008) Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Aliment Pharmacol Ther 28(10):1221–1229CrossRefPubMed Sipponen T, Kärkkäinen P, Savilahti E, et al. (2008) Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Aliment Pharmacol Ther 28(10):1221–1229CrossRefPubMed
24.
go back to reference van Rheenen PF, Van de Vijver E, Fidler V (2010) Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 341(jul15 1):c3369CrossRefPubMedPubMedCentral van Rheenen PF, Van de Vijver E, Fidler V (2010) Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 341(jul15 1):c3369CrossRefPubMedPubMedCentral
25.
go back to reference Menys A, Atkinson D, Odille F, et al. (2012) Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn’s disease activity: a preliminary study. Eur Radiol 22(11):2494–2501CrossRefPubMed Menys A, Atkinson D, Odille F, et al. (2012) Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn’s disease activity: a preliminary study. Eur Radiol 22(11):2494–2501CrossRefPubMed
26.
go back to reference Tielbeek JAW, Ziech MLW, Li Z, et al. (2014) Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol 24(3):619–629CrossRefPubMed Tielbeek JAW, Ziech MLW, Li Z, et al. (2014) Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol 24(3):619–629CrossRefPubMed
27.
go back to reference Panes J, Bouhnik Y, Reinisch W, et al. (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7(7):556–585CrossRefPubMed Panes J, Bouhnik Y, Reinisch W, et al. (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7(7):556–585CrossRefPubMed
Metadata
Title
Diffusion-weighted imaging for evaluating inflammatory activity in Crohn’s disease: comparison with histopathology, conventional MRI activity scores, and faecal calprotectin
Authors
D. A. Pendsé
J. C. Makanyanga
A. A. Plumb
G. Bhatnagar
D. Atkinson
Manuel Rodriguez-Justo
S. Halligan
S. A. Taylor
Publication date
01-01-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0863-z

Other articles of this Issue 1/2017

Abdominal Radiology 1/2017 Go to the issue

Classics in Abdominal Imaging

The embedded organ sign

Classics in Abdominal Imaging

The “eggplant penis” sign